Form 4: Organon & Co. Executive Aaron Falcione Reports Stock Transactions
SEC Form 4
Aaron Falcione, Chief Human Resources Officer of Organon & Co., reports the vesting and disposition of restricted stock units.
Summary
- On March 31, 2024, Aaron Falcione, Chief Human Resources Officer of Organon & Co., reported transactions involving Organon common stock.
- These transactions included the vesting of restricted stock units (RSUs) and the subsequent disposition of shares to cover tax obligations.
- Specifically, 3,578 RSUs vested, converting into 3,578 shares of Organon common stock.
- Additionally, 6,731 RSUs vested, converting into 6,731 shares of Organon common stock.
- Falcione disposed of 1,226 shares at $18.8 to cover tax obligations related to the vesting of the first set of RSUs.
- Falcione disposed of 2,306 shares at $18.8 to cover tax obligations related to the vesting of the second set of RSUs.
- Following these transactions, Falcione directly owns 28,594 shares of Organon common stock and 13,464 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine filing related to executive compensation, with no indication of positive or negative sentiment.
Future Outlook
The remaining RSUs will vest on March 31, 2025, and March 31, 2026.
Industry Context
Form 4 filings are a routine part of executive compensation and provide transparency into insider transactions, which are closely monitored by investors.
Comparison to Industry Standards
- Executive compensation packages often include restricted stock units that vest over time, aligning executive interests with long-term shareholder value.
- The vesting schedules and tax-related dispositions are typical components of RSU agreements.
- Comparing Falcione's holdings and transactions to those of executives at similar pharmaceutical companies (e.g., Viatris, Teva) could provide context on the scale of equity compensation.
Stakeholder Impact
- The transactions have a minimal direct impact on stakeholders, as they are related to executive compensation and tax obligations.
Key Dates
| Date | Description |
|---|---|
| 03/31/2023 | One-third of the RSUs vested. |
| 03/31/2024 | Date of the reported transactions, including vesting of RSUs and disposition of shares. |
| 03/31/2025 | Remaining RSUs to vest. |
| 03/31/2026 | Remaining RSUs to vest. |
| 04/03/2024 | Date of signature for the Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.